This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street

Although now mature, the weight-loss drug market remains strong and growing. The top GLP-1 drug competitors were first to market, but not racing to the finish line has given some drug developers more time to develop a more marketable alternative.